We are live on
!
Find out more
BCM
Brooktree Capital Management Portfolio holdings
AUM
$153M
1-Year Est. Return
14.06%
This Fund
S&P 500
This Quarter
Est. Return
-1.4%
1 Year Est. Return
+14.06%
3 Year Est. Return
+82.89%
5 Year Est. Return
+68.3%
10 Year Est. Return
–
AUM
$157M
AUM Growth
+$1.15M
(+0.74%)
Cap. Flow
+$6.55M
Cap. Flow
% of AUM
4.17%
Top 10 Holdings %
Top 10 Hldgs %
61.68%
Holding
44
New
2
Increased
9
Reduced
23
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$7.34M |
| 2 |
Rimini Street
RMNI
|
+$2.74M |
| 3 |
Thryv Holdings
THRY
|
+$1.53M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$340K |
| 5 |
PAR Technology
PAR
|
+$227K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cimpress
CMPR
|
+$1.84M |
| 2 |
PepsiCo
PEP
|
+$792K |
| 3 |
SHSP
SharpSpring, Inc.
SHSP
|
+$595K |
| 4 |
Procter & Gamble
PG
|
+$456K |
| 5 |
Honeywell
HON
|
+$425K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.92% |
| 2 | Financials | 22.71% |
| 3 | Healthcare | 11.68% |
| 4 | Industrials | 9.06% |
| 5 | Consumer Discretionary | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
AbbVie
ABBV
$454B
| $1.72M | 1.1% |
15,966
-912
| -5% | -$104K |
|
27
Abbott
ABT
$176B
| $1.55M | 0.99% |
13,156
-965
| -7% | -$119K |
|
|
CVET
28
DELISTED
Covetrus, Inc. Common Stock
CVET
| $1.28M | 0.82% |
70,767
| – | – |
|
29
Lam Research
LRCX
$373B
| $1.13M | 0.72% |
19,900
-2,620
| -12% | -$159K |
|
30
S&P Global
SPGI
$121B
| $1.1M | 0.7% |
2,583
-2
| -0.1% | -$867 |
|
|
31
PepsiCo
PEP
$186B
| $1.09M | 0.7% |
7,265
-5,119
| -41% | -$792K |
|
32
Rocket Companies
RKT
$37.3B
| $997K | 0.64% |
62,164
+1,472
| +2% | +$25.7K |
|
33
Lockheed Martin
LMT
$121B
| $568K | 0.36% |
1,645
-215
| -12% | -$77.8K |
|
|
FITB
34
Fifth Third Bancorp
FITB
$49.6B
| $547K | 0.35% |
12,900
-4,000
| -24% | -$153K |
|
35
Verisk Analytics
VRSK
$22.9B
| $488K | 0.31% |
2,438
-94
| -4% | -$18.2K |
|
36
Thermo Fisher Scientific
TMO
$225B
| $409K | 0.26% |
716
-321
| -31% | -$176K |
|
37
Fortune Brands Innovations
FBIN
$4.86B
| $404K | 0.26% |
5,288
-301
| -5% | -$25K |
|
|
38
Alphabet (Google) Class A
GOOGL
$4.14T
| $334K | 0.21% |
+2,500
| New | +$340K |
|
39
3M
MMM
$85.1B
| $309K | 0.2% |
2,109
-59
| -3% | -$9.56K |
|
40
Merck
MRK
$355B
| $259K | 0.17% |
3,446
-1
| -0% | -$76 |
|
41
Stryker
SYK
$106B
| $211K | 0.13% |
800
| – | – |
|
42
Cummins
CMI
$76.6B
| – | – |
-874
| Closed | -$213K |
|
43
Novartis
NVS
$261B
| – | – |
-2,542
| Closed | -$232K |
|
|
SHSP
44
DELISTED
SharpSpring, Inc.
SHSP
| – | – |
-35,213
| Closed | -$595K |
|
Similar funds
RWM
MWA
FFG
PA
PB
DFG
ACM
MVA
Brooktree Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Brooktree Capital Management held 44 positions worth $157M, up 0.74% from $156M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Brooktree Capital Management deployed $6.55M of net new capital in Q3 2021, opening 2 new positions and adding to 9 existing holdings. Its largest new stake was People Inc: 66,566 shares worth $7.12M.
By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 45% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cimpress, an estimated $1.84M trimmed.
- Brooktree Capital Management's largest Q3 2021 buy was People Inc: 66,566 shares worth $7.12M.
- Brooktree Capital Management added most to Rimini Street in Q3 2021, an estimated $2.74M increase.
- Brooktree Capital Management's biggest Q3 2021 reduction was Cimpress, cutting an estimated $1.84M.
- Brooktree Capital Management fully exited SharpSpring, Inc. in Q3 2021, selling an estimated $595K.
- Brooktree Capital Management's ten largest holdings make up 62% of its $157M portfolio in Q3 2021.
- Brooktree Capital Management opened 2 new positions and closed 3 in Q3 2021.
- Brooktree Capital Management's portfolio value rose 0.74% quarter-over-quarter to $157M.
Based on Brooktree Capital Management's 13F filing for Q3 2021, filed 9 Nov 2021.